Antharis Therapeutics

Antharis Therapeutics

Biotechnology, San Diego, California, United States, 11-50 Employees

antharistherapeutics.com

  • LinkedIn

Who is ANTHARIS THERAPEUTICS

Antharis Therapeutics is a multinational biopharmaceutical company developing new treatments for cancer, inflammatory and infectious diseases. In particular, our company utilizes cutting-...

Read More

map
  • San Diego, California, United States Headquarters: San Diego, California, United States
  • 2020 Date Founded: 2020
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ANTHARIS THERAPEUTICS

Antharis Therapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Antharis Therapeutics

Answer: Antharis Therapeutics's headquarters are located at San Diego, California, United States

Answer: Antharis Therapeutics's official website is https://antharistherapeutics.com

Answer: Antharis Therapeutics's revenue is Under $1 Million

Answer: Antharis Therapeutics's SIC: 8731

Answer: Antharis Therapeutics's NAICS: 541714

Answer: Antharis Therapeutics has 11-50 employees

Answer: Antharis Therapeutics is in Biotechnology

Answer: Antharis Therapeutics contact info: Phone number: Website: https://antharistherapeutics.com

Answer: Antharis Therapeutics is a multinational biopharmaceutical company developing new treatments for cancer, inflammatory and infectious diseases. In particular, our company utilizes cutting-edge science to develop therapeutic monoclonal antibodies and antibody-drug conjugates with the end goal of treating unmet medical needs. The company, founded by Dr. Raphael R Pinaud in 2020, has significantly grown and successfully advanced its mission to date. Furthermore, Antharis strategically acquired Cassyni Biopharma and Galileo Biotech, in mid-2022 and mid-2023, respectively, to further and more effectively advance its mandate to bring transformational therapies to patients in need.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access